Literature DB >> 18547944

Factors predicting bacterial involvement in severe acute exacerbations of chronic obstructive pulmonary disease.

Saad Nseir1, Béatrice Cavestri, Christophe Di Pompeo, Maimouna Diarra, Hélène Brisson, Malcolm Lemyze, Micheline Roussel-Delvallez, Alain Durocher.   

Abstract

BACKGROUND: Strategies aiming at reducing antibiotic use are required in the intensive care unit (ICU). Although antibiotic treatment is recommended in patients with severe exacerbation of chronic obstructive pulmonary disease (COPD), a bacterial etiology is found in only a half of these patients.
OBJECTIVES: The aim of this study was to determine factors predicting bacterial isolation in severe acute exacerbations of COPD.
METHODS: All patients with severe acute exacerbation of COPD requiring intubation and mechanical ventilation were included in this prospective observational cohort study. At ICU admission, information on endotracheal aspirate purulence and hyperthermia was collected. In all patients, Gram stain and quantitative endotracheal aspirate culture (positive at 10(6) cfu/ml) were performed. In addition, leukocyte count, C-reactive protein and procalcitonin (PCT) levels were measured.
RESULTS: Ninety-eight severe acute exacerbations of COPD requiring intubation and mechanical ventilation were studied. Forty-nine bacteria were isolated at significant threshold in 40 exacerbations. Streptococcus pneumoniae (16%), methicillin-sensitive Staphylococcus aureus (16%) and Hemophilus influenzae (14%) were the most frequently isolated bacteria. PCT >0.5 ng/ml and positive Gram stain of endotracheal aspirate were independently associated with bacterial isolation in severe acute exacerbation of COPD. Positive Gram stain and PCT >0.5 ng/ml had a negative predictive value >95%. Similar results were found after excluding patients with prior antibiotic treatment.
CONCLUSION: Positive Gram stain of endotracheal aspirate and PCT >0.5 ng/ml are independently associated with bacterial isolation in severe acute exacerbation of COPD. These results could be helpful for future interventional studies aiming at reducing antibiotic use in these patients. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18547944     DOI: 10.1159/000139611

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  8 in total

1.  Optimal cut-off value of serum procalcitonin in predicting bacterial infection induced acute exacerbation in chronic obstructive pulmonary disease: A prospective observational study.

Authors:  Yan-Ping Ye; Hang Zhao; Tao Kang; Li-Hua Zhao; Ning Li; Jing Chen; Xiao-Xia Peng
Journal:  Chron Respir Dis       Date:  2022 Jan-Dec       Impact factor: 3.115

2.  Biomarkers to guide the use of antibiotics for acute exacerbations of COPD (AECOPD): a systematic review and meta-analysis.

Authors:  George Hoult; David Gillespie; Tom M A Wilkinson; Mike Thomas; Nick A Francis
Journal:  BMC Pulm Med       Date:  2022-05-13       Impact factor: 3.320

3.  The role of toll-like receptors in acute and chronic lung inflammation.

Authors:  Erin I Lafferty; Salman T Qureshi; Markus Schnare
Journal:  J Inflamm (Lond)       Date:  2010-11-25       Impact factor: 4.981

4.  Potentially preventable hospitalizations for acute and chronic conditions in Alaska, 2010-2012.

Authors:  Prabhu P Gounder; Sara M Seeman; Robert C Holman; Alice Rarig; Mary K McEwen; Claudia A Steiner; Michael L Bartholomew; Thomas W Hennessy
Journal:  Prev Med Rep       Date:  2016-04-04

Review 5.  The recent advances of phenotypes in acute exacerbations of COPD.

Authors:  Aiyuan Zhou; Zijing Zhou; Yiyang Zhao; Ping Chen
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-03-27

Review 6.  Host-pathogen interaction during mechanical ventilation: systemic or compartmentalized response?

Authors:  Sean Keane; Ignacio Martin-Loeches
Journal:  Crit Care       Date:  2019-06-14       Impact factor: 9.097

7.  HL301 in the treatment of acute bronchitis: a phase 2b, randomized, double-blind, placebocontrolled, multicenter study.

Authors:  Sang Won Yoon; Myung Jae Park; Chin Kook Rhee; Joo Hun Park; Sang Yeub Lee; Do Jin Kim; Dong Gyu Kim; Jae Yeol Kim
Journal:  Korean J Intern Med       Date:  2019-04-09       Impact factor: 2.884

Review 8.  The Use of Serum Procalcitonin as a Diagnostic and Prognostic Biomarker in Chronic Obstructive Pulmonary Disease Exacerbations: A Literature Review Update.

Authors:  Nikolaos-Dimitrios Pantzaris; Diamantina-Xanthi Spilioti; Aikaterini Psaromyalou; Ioanna Koniari; Dimitrios Velissaris
Journal:  J Clin Med Res       Date:  2018-06-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.